Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial

European Journal of Cancer

Volumn 32, Issue 5, 1996, Pages 814-820

  Viscoli, C ^a   Castagnola, E ^b   Van Lint, M T ^a   Moroni, C ^b   Garaventa, A ^b   Rossi, M R ^c   Fanci, R ^d   Menichetti, F ^e   Caselli, D ^f   Giacchino, M ^g   Congiu, M ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

Author keywords

Antifungal therapy; Cancer; Fever; Neutropenia

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; HYPOKALEMIA; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOSIS; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; AGRANULOCYTOSIS; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; FLUCONAZOLE; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; MALE; MIDDLE AGED; MYCOSES; NEOPLASMS; OPPORTUNISTIC INFECTIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 8944229202     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00619-2     Document Type: Article

References (28)

1. Armstrong D, Young LS, Meyer RD, Blevins AH. Infectious complications of neoplastic disease. Med Clin North Am 1971, 55, 729-745.
2. Klastersky J, Zinner SH, Calandra T, et al. Empiric antimicrobial therapy for febrile, granulocytopenic cancer patients: lessons from 4 EORTC trials. Eur J Cancer Clin Oncol 1988, 24 (Suppl. 1), s35-s45a.
3. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982, 72, 101-111.
4. EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 1989, 86, 668-672.
5. Gallis HA, Drew RH, Pickard A. Amphotericin B: 30 years of clinical experience. Rev Infect Dis 1990, 12, 308-329.
6. Walsh TJ. Management of immunocompromised patients with evidence of invasive mycosis. Hematol Oncol Clin North Am 1993, 5, 1003-1026.
7. Milatovic D, Vos A. Efficacy of fluconazole in the treatment of systemic fungal infections. Eur J Clin Microbiol Infect Dis 1992, 11, 395-402.
8. Meunier F. Fluconazole treatment of fungal infections in the immunocompromised host. Semin Oncol 1990, 17 (Suppl. 6), 19-23.
9. Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992, 326, 845-851.
10. Winston DJ, Chandrasekar PH, Lazarus HM, et al. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multi-center trial. Ann Intern Med 1993, 118, 495-503.
11. Menichetti F, Del Favero A, Martino P, et al. and the Gimema Infection Program. Preventing fungal infection in granulocytopenic patients with acute leukemia: fluconazole compared with oral Amphotericin B. Ann Intern Med 1994, 120, 913-918.
12. Wingard JR, Merz WG, Rinaldi MG, et al. Increase in Candida krusei infection among patients with bone marrow transplantation and granulocytopenia treated prophylactically with fluconazole. N Engl J Med 1991, 325, 1274-1277.
13. Wingard JR, Merz WG, Rinaldi MG, Miller CB, Karp JE, Saral R. Association of Torulopsis glabrata infection with fluconazole prophylaxis in granulocytopenic bone marrow transplant patients. Antimicrob Agents Chemother 1993, 37, 1847-1849.
14. Consensus Panel of the Immunocompromised Host Society. The design, analysis and reporting of clinical trials on the empirical antibiotic management of the granulocytopenic patient. J Infect Dis 1990, 161, 397-401.
15. BodeyJ. Fungal infections complicating acute leukemia. J Chronic Dis 1966, 19, 667-687.
16. Mirsky HS, Cuttner J. Fungal infection in acute leukemia. Cancer 1972, 30, 348-352.
17. Myerwitz RL, Pazin GJ, Allen CM. Disseminated candidiasis. Changes in incidence, underlying disease and pathology. Am J Clin Pathol 1977, 68, 29-38.
18. Aisner J, Schimpff S, Wiernik H. Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Intern Med 1977, 86, 539-543.
19. Burke PJ, Braine HG, Rathbun HK, et al. The clinical significance and management of fever in acute myelocytic leukemia. John Hopkins Med J 1976, 139, 1-12.
20. Pizzo PA, Robichaud KJ, Gill FA, et al. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982, 72, 101-110.
21. Talcott JA, Findberg R, Mayer RJ, Goldman L. The medical course of cancer patients with fever and neutropenia. Arch Intern Med 1988, 148, 2561-2567.
22. Talcott JA, Siegel RD, Finberg R, Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol 1992, 10, 316-322.
23. Viscoli C, Bruzzi P, Castagnola E, et al. and the International Antimicrobial Therapy Cooperative Group of the EORTC. Factors associated bacteraemia in febrile, granulocytopenic cancer patients. Eur J Cancer 1994, 30A, 430-437.
24. Guiot HFL, Fibbe WE, van't Wout. Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clin Infect Dis 1994, 18, 525-532.
25. O'Donnell MR, Schmidt GM, Tegtmeier GM, et al. Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin B prophylaxis in high-risk patients. J Clin Oncol 1994, 12, 827-834.
26. Walsh TJ, Hiemenz J, Pizzo PA. Editorial response: evolving risk factors for invasive fungal infections - All neutropenic patients are not the same. Clin Infect Dis 1994, 18, 793-798.
27. Viscoli C, Castagnola E, Fioredda F, Ciravegna B, Barigione G, Terragna A. Fluconazole in the treatment of candidiasis in immunocompromised children. Antimicrob Agents Chemother 1991, 35, 365-367.
28. Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann M. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol 1994, 32, 2092-2098.